Metabolic and Bariatric Surgery · 11 November 2023

Gastric Bypass: A Shield Against Esophageal Adenocarcinoma in Obesity

In a Nordic cohort study, researchers explored if bariatric surgery lowers esophageal and cardia adenocarcinoma risks linked to obesity. Of 748,932 participants, mainly undergoing gastric bypass, the surgery showed a significant decrease in esophageal adenocarcinoma risk over time, suggesting it may counteract its development in morbidly obese individuals. The study implies gastric bypass as a potential preventive measure against esophageal adenocarcinoma in the long term for those struggling with obesity.

Journal Article by Hardvik Åkerström J, Santoni G (…) Lagergren J et 7 al. in Ann Surg

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

Ann Surg13 Jul 2026

Predictive Models Enhance Diabetes Remission After Surgery

A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.

Ann Surg16 Jun 2026

EndoBarrier Shows Promise for Type 2 Diabetes in Obesity

Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.

All papers in Metabolic and Bariatric Surgery →